Minoryx Therapeutics recluta anticipadamente los pacientes para su ensayo clínico ADVANCE de fase II/III

by Minoryx Therapeutics

Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces the dosing of its first US patient as part of its ongoing phase 2/3 clinical trial of ...

Read more

Minoryx inicia el ensayo de fase II/III del tratamiento para la adrenomieloneuropatía

by Minoryx Therapeutics

El primer paciente con esta enfermedad rara que ha iniciado el tratamiento con MIN-102 ha sido en el Hospital Vall d'Hebron de Barcelona. El estudio, denominado ADVANCE, reclutará en total a 100 paci...

Read more
Subscribe to Directory
Write an Article

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

The CNIO and Hospital 12 de Octubre find...

by CNIO - Centro Nacional de Investigaciones Oncológicas

Myelofibrosis is a very rare serious disease that affects bone marrow ...

Photos Stream